Boardroom Alpha
Boardroom Alpha
DVA · Additional Proxy Materials (DEFA14A) · Filed April 22, 2026

Davita Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 22, 2026
Ticker
DVA
Accession
0001206774-26-000234
About Davita Inc
Market cap
$12.2B
1Y TSR
+37.0%
3Y TSR
+24.5%
Board grade
B
Sector
Healthcare
CEO
Javier Rodriguez
Last annual meeting: Jun 4, 2026 · View full Davita Inc profile →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.  )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under §240.14a-12
DAVITA INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 


           
     

Your Vote Counts!

 

DAVITA INC.

 

2026 Annual Meeting
Vote by June 3, 2026 11:59 PM ET.
For shares held in the DaVita Retirement Savings Plan, vote by
June 2, 2026 11:59 PM ET.

 

 

 

DAVITA INC.

2000 16TH STREET

DENVER, CO 80202

 
 
V93936-P48365      
           

 

You invested in DAVITA INC. and it’s time to vote!

You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the 2026 Annual Meeting of the Stockholders to be held on June 4, 2026.

 

Get informed before you vote

View the Annual Report, Notice and Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 21, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

 

For complete information and to vote, visit www.ProxyVote.com
Control #
     

 

Smartphone users

Point your camera here and
vote without entering a
control number

 

Vote Virtually at the Meeting*

 

June 4, 2026
10:00 AM Mountain Time

 

Virtually at:
www.virtualshareholdermeeting.com/DVA2026

   

 

* Please check the meeting materials for any special requirements for meeting attendance.  

 

 

Vote at www.ProxyVote.com

 

 

THIS IS NOT A VOTABLE BALLOT

 

This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.

 

 

Voting Items Board
Recommends
1.

Election of Directors

Nominees: 

 
1a. Pamela M. Arway For
1b. Barbara J. Desoer For
1c. Jason M. Hollar For
1d. Gregory J. Moore, MD, PhD For
1e. Dennis W. Pullin For
1f. Javier J. Rodriguez For
1g. Adam H. Schechter For
1h. Wendy L. Schoppert For
1i. Phyllis R. Yale For
2. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2026. For
3. To approve, on an advisory basis, the compensation of our named executive officers. For
NOTE: The proxy holders are entitled to vote in their discretion on such other business as may properly be brought before the meeting or any adjournment or postponement thereof.  
     
     
     
     
     
     
     
     
     
     
     
     
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.

V93937-P48365

 

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Davita Inc (DVA)

Reference

Frequently asked questions

When did Davita Inc file this DEFA14A?
Davita Inc (DVA) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 22, 2026. The accession number assigned by EDGAR is 0001206774-26-000234.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
Where can I find Davita Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Davita Inc has filed under CIK 927066, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer